Status:
COMPLETED
Executive Function Disorders and Anxio-depressive Symptomatology in Children and Adolescents With Mitochondrial Pathologies
Lead Sponsor:
University Hospital, Angers
Conditions:
Mitochondrial Diseases
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
The major steps forward of the neurosciences in recent years have linked psychiatric diseases, neuropsychological symptoms and brain dysfunctions. The cerebral functioning requiring a big quantity of ...
Eligibility Criteria
Inclusion
- Child with mitochondrial cytopathy (defined by the presence of a mutation known to cause mitochondrial cytopathy or mitochondrial respiratory chain abnormality)
- Aged 6 to 17 years
- Beneficiary of a Social Security regime
- Parents sign consent
Exclusion
- Child refusal to participate in the study
- Complete inability to complete questionnaires (e.g. non-communicating child)
- Child already included in intervention research modifying care
Key Trial Info
Start Date :
May 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03832218
Start Date
May 2 2019
End Date
February 27 2020
Last Update
November 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr RIQUIN Elise
Angers, France